Advertisement
AVAH vs PNTG
Which Stock Would AI Choose? Aveanna Healthcare (AVAH) vs. The Pennant Group (PNTG) Stock Comparison
Key Takeaways
- AVAH is a large, pediatric-focused home care platform, while PNTG is a smaller, acquisition-driven operator of home health, hospice, and senior living services.
- Both stocks delivered strong recent earnings beats, but their growth engines differ: AVAH is levered to private-duty nursing and reimbursement rates, while PNTG is powered by rapid integration of newly acquired operations.
- AVAH carries a heavier debt load tied to variable-rate borrowings, whereas PNTG operates with lower leverage and an active merger and acquisition (M&A) pipeline.
- Relative performance has favored AVAH over the past year, though PNTG has shown more consistent, organic margin improvement across its segments.
- Key risks include Medicaid and Medicare reimbursement policy, caregiver labor shortages, and execution during large-scale integration for PNTG.
- Tickeron's AI framework tends to favor trend consistency and stability, which can shift the verdict between these two names depending on the timeframe analyzed.
Introduction
Investors evaluating healthcare services often face a choice between scale and specialization. This stock comparison examines two publicly traded home-based care providers that operate in overlapping markets but pursue very different strategies. AVAH, or Aveanna Healthcare Holdings Inc., focuses heavily on pediatric private-duty nursing and medical solutions. PNTG, or The Pennant Group, Inc., concentrates on home health, hospice, and senior living across western, midwestern, and newly added southeastern states. Both names have attracted analyst attention recently, making a head-to-head review of their relative performance and market positioning timely for growth-oriented and income-focused investors alike.
AVAH Overview and Recent Performance
Aveanna Healthcare Holdings Inc. operates a national platform delivering home care for pediatric, adult, and geriatric patients. Its largest segment, Private Duty Services, serves medically complex children, while Home Health & Hospice and Medical Solutions (enteral nutrition) round out the business. Recent market activity has been defined by a multi-quarter streak of earnings beats, a completed acquisition of Family First Homecare that strengthened its Florida footprint, and raised full-year guidance. The company now projects revenue in the range of roughly $2.63 billion to $2.65 billion, reflecting double-digit top-line growth and improving adjusted earnings before interest, taxes, depreciation, and amortization (adjusted EBITDA).
Sentiment has been buoyed by multiple analyst upgrades, citing solid execution on preferred-payer relationships and improving cash generation. The stock has reached 52-week highs in recent weeks after a strong run, though it remains sensitive to policy headlines. The primary overhangs are a substantial variable-rate debt balance, concentration in Medicaid and Medicare funding, and persistent caregiver wage pressure, all of which can amplify volatility when reimbursement policy shifts.
PNTG Overview and Recent Performance
The Pennant Group, Inc. was spun off from The Ensign Group in 2019 to focus on non-skilled-nursing healthcare. It operates two segments: Home Health and Hospice Services, and Senior Living Services. Recent quarters have featured outsized revenue growth driven largely by acquisitions, including a large expansion into Tennessee, Alabama, and Georgia. The company reported double-digit year-over-year revenue and adjusted EBITDA gains, with same-store margins improving despite a modest home health reimbursement rate reduction and ongoing wage pressure.
Management has emphasized operational integration of more than 50 newly added operations, framing the effort as a multi-wave transition expected to continue through late 2026. In recent weeks, PNTG raised its annual guidance and pointed to the upper end of its original range, supported by organic census growth and disciplined M&A execution. The stock has climbed toward its 52-week high and carries a consensus "Strong Buy" rating, though integration costs, electronic medical record transitions, and reimbursement cyclicality remain the key watch items.
Trending AI Robots
For traders seeking a data-driven edge, Tickeron's Trending AI Robots page curates a selection of algorithmic trading bots from a much larger universe. Tickeron hosts hundreds of AI trading bots that collectively monitor and trade thousands of different tickers, but only those best suited to current market conditions earn a place in this rotating, curated list. Each bot has its own trading style, strategy, timeframe, performance statistics, and set of tickers it follows, allowing users to compare approaches rather than relying on a one-size-fits-all signal. Because the featured robots are selected for their alignment with prevailing market dynamics, the page offers a useful starting point for those researching automated strategies across names like healthcare providers and beyond. Explore the Trending AI Robots section to review current selections and performance metrics.
Head-to-Head Comparison
The most striking contrast between these two names is scale versus specialization. AVAH is a substantially larger revenue base built around pediatric private-duty nursing, where demand is structurally strong but reimbursement is heavily government-dependent. PNTG is a mid-cap consolidator that grows through acquisitions and same-store operating discipline across home health, hospice, and senior living.
On growth drivers, AVAH leans on preferred-payer agreements, rate integrity advocacy, and capacity expansion through caregiver hiring. PNTG leans on acquiring and improving underperforming assets, then unlocking margin through its localized leadership model. In terms of momentum, both stocks have trended upward, but AVAH's year-to-date gains have been more pronounced, partly reflecting a rebound from a depressed valuation. PNTG has delivered steadier, more balanced growth with lower financial leverage.
Risk profiles also diverge. AVAH's variable-rate debt and policy sensitivity create greater downside exposure if rates or reimbursement shift. PNTG faces integration risk from its rapid expansion and a home health reimbursement environment that has seen consecutive annual base-rate reductions, offset by a more constructive proposed hospice rate rule. Sector exposure overlaps in home health and hospice, but AVAH's pediatric private-duty franchise and PNTG's senior living portfolio represent distinct value propositions.
Tickeron AI Verdict
Based on observable factors, Tickeron's AI would likely assign a modest edge to PNTG on stability and trend consistency, given its lower leverage, improving same-store margins, and constructive analyst consensus. At the same time, AVAH has demonstrated stronger near-term momentum and more pronounced analyst upgrades, which a momentum-oriented model might favor. In probabilistic terms, the AI framework would likely view PNTG as the steadier, lower-risk compounder and AVAH as the higher-beta recovery play with greater upside potential but elevated financial risk. The favored name therefore depends on the strategy's timeframe and risk tolerance rather than any single definitive signal.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AVAH is a Hold and PNTG is a Hold.
AVAH's RSI Indicator leaves overbought zone
The 10-day RSI Oscillator for AVAH moved out of overbought territory on November 05, 2026. This could be a sign that the stock is shifting from an upward trend to a downward trend. Traders may want to look at selling the stock or buying put options. Tickeron's A.I.dvisor looked at 28 instances where the indicator moved out of the overbought zone. In 26 of the 28 cases the stock moved lower in the days that followed. This puts the odds of a move down at 90%.
Technical Analysis (Indicators)
Bearish Trend Analysis
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 50 of 56 cases where AVAH's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 89%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where AVAH declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 87%.
AVAH broke above its upper Bollinger Band on November 04, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
Bullish Trend Analysis
The Momentum Indicator moved above the 0 level on November 09, 2026. You may want to consider a long position or call options on AVAH as a result. In 80 of 95 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 84%.
The Moving Average Convergence Divergence (MACD) for AVAH just turned positive on October 20, 2026. Looking at past instances where AVAH's MACD turned positive, the stock continued to rise in 32 of 40 cases over the following month. The odds of a continued upward trend are 80%.
AVAH moved above its 50-day moving average on October 29, 2026 date and that indicates a change from a downward trend to an upward trend.
The 10-day moving average for AVAH crossed bullishly above the 50-day moving average on November 03, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 12 of 17 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 71%.
Following a +8.46% 3-day Advance, the price is estimated to grow further. Considering data from situations where AVAH advanced for three days, in 198 of 248 cases, the price rose further within the following month. The odds of a continued upward trend are 80%.
The Aroon Indicator entered an Uptrend today. In 141 of 177 cases where AVAH Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 80%.
Fundamental Analysis (Ratings)
The Tickeron SMR rating for this company is 11 (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Price Growth Rating for this company is 35 (best 1 - 100 worst), indicating steady price growth. AVAH’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 53 (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 83, placing this stock slightly better than average.
The Tickeron Valuation Rating of 57 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (10.043) is normal, around the industry mean (204.532). P/E Ratio (9.962) is within average values for comparable stocks, (21.572). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.498). Dividend Yield (0.000) settles around the average of (0.154) among similar stocks. P/S Ratio (1.223) is also within normal values, averaging (2.688).
The Tickeron PE Growth Rating for this company is 92 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
PNTG in downward trend: 10-day moving average broke below 50-day moving average on November 10, 2026
The 10-day moving average for PNTG crossed bearishly below the 50-day moving average on November 10, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 14 of 18 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 78%.
Technical Analysis (Indicators)
Bearish Trend Analysis
The Momentum Indicator moved below the 0 level on November 05, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on PNTG as a result. In 60 of 91 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 66%.
The Moving Average Convergence Divergence Histogram (MACD) for PNTG turned negative on November 05, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 53 similar instances when the indicator turned negative. In 34 of the 53 cases the stock turned lower in the days that followed. This puts the odds of success at 64%.
PNTG moved below its 50-day moving average on November 05, 2026 date and that indicates a change from an upward trend to a downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where PNTG declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 72%.
Bullish Trend Analysis
The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 1 day, which means it's wise to expect a price bounce in the near future.
Following a +8.74% 3-day Advance, the price is estimated to grow further. Considering data from situations where PNTG advanced for three days, in 244 of 313 cases, the price rose further within the following month. The odds of a continued upward trend are 78%.
PNTG may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Aroon Indicator entered an Uptrend today. In 181 of 236 cases where PNTG Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 77%.
Fundamental Analysis (Ratings)
The Tickeron PE Growth Rating for this company is 22 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 54 (best 1 - 100 worst), indicating fairly steady price growth. PNTG’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 56 (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 83, placing this stock slightly better than average.
The Tickeron SMR rating for this company is 72 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Valuation Rating of 85 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.536) is normal, around the industry mean (204.532). P/E Ratio (38.681) is within average values for comparable stocks, (21.572). Projected Growth (PEG Ratio) (2.017) is also within normal values, averaging (2.498). Dividend Yield (0.000) settles around the average of (0.154) among similar stocks. P/S Ratio (1.373) is also within normal values, averaging (2.688).
PNTG | ||
|---|---|---|
OUTLOOK RATING 1..100 | 71 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 85 Overvalued | |
PROFIT vs RISK RATING 1..100 | 56 | |
SMR RATING 1..100 | 72 | |
PRICE GROWTH RATING 1..100 | 54 | |
P/E GROWTH RATING 1..100 | 22 | |
SEASONALITY SCORE 1..100 | 35 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
| AVAH | PNTG | |
|---|---|---|
| RSI ODDS (%) | 2 days ago 90% | N/A |
| Stochastic ODDS (%) | 2 days ago 89% | 2 days ago 79% |
| Momentum ODDS (%) | 2 days ago 84% | 2 days ago 66% |
| MACD ODDS (%) | 2 days ago 80% | 2 days ago 64% |
| TrendWeek ODDS (%) | 2 days ago 86% | 2 days ago 71% |
| TrendMonth ODDS (%) | 2 days ago 82% | 2 days ago 75% |
| Advances ODDS (%) | 8 days ago 80% | 8 days ago 78% |
| Declines ODDS (%) | 2 days ago 87% | 3 days ago 72% |
| BollingerBands ODDS (%) | 2 days ago 81% | 2 days ago 77% |
| Aroon ODDS (%) | 2 days ago 80% | 2 days ago 77% |
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
AVAH’s FA Score shows that 1 FA rating(s) are green while PNTG’s FA Score has 1 green FA rating(s).
- AVAH’s FA Score: 1 green, 4 red.
- PNTG’s FA Score: 1 green, 4 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
AVAH’s TA Score shows that 6 TA indicator(s) are bullish while PNTG’s TA Score has 4 bullish TA indicator(s).
- AVAH’s TA Score: 6 bullish, 4 bearish.
- PNTG’s TA Score: 4 bullish, 5 bearish.
Price Growth
AVAH (@Hospital/Nursing Management) experienced а -0.68% price change this week, while PNTG (@Hospital/Nursing Management) price change was -10.80% for the same time period.
The average weekly price growth across all stocks in the @Hospital/Nursing Management industry was -5.75%. For the same industry, the average monthly price growth was +0.37%, and the average quarterly price growth was +10.84%.
Reported Earning Dates
AVAH is expected to report earnings on Nov 12, 2026.
PNTG is expected to report earnings on Mar 03, 2027.
Industries' Descriptions
@Hospital/Nursing Management (-5.75% weekly)Hospital/Nursing Management companies own and operate health care facilities. Their operations include nursing homes, acute care facilities, retirement centers and outpatient surgery centers. HCA Healthcare Inc., Alcon Inc. and Universal Health Services, Inc. are some major companies in this industry. Technology has been at the forefront of development of advanced solutions, including quicker diagnoses of complex conditions. Investments in new diagnostics, healthcare IoT, and other healthcare technologies continue to gather momentum in this industry.
Advertisement
AVAH and
Correlation & Price change
A.I.dvisor indicates that over the last year, AVAH has been loosely correlated with PNTG. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if AVAH jumps, then PNTG could also see price increases.
| Ticker / NAME | Correlation To AVAH | 1D Price Change % | ||
|---|---|---|---|---|
| AVAH | 100% | -0.08% | ||
| PNTG - AVAH | 43% Loosely correlated | +1.32% | ||
| CON - AVAH | 33% Poorly correlated | +0.64% | ||
| ENSG - AVAH | 31% Poorly correlated | +1.64% | ||
| HCSG - AVAH | 30% Poorly correlated | +2.10% | ||
| THC - AVAH | 29% Poorly correlated | +0.44% | ||
More | ||||
PNTG and
Correlation & Price change
A.I.dvisor indicates that over the last year, PNTG has been loosely correlated with ADUS. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if PNTG jumps, then ADUS could also see price increases.
| Ticker / NAME | Correlation To PNTG | 1D Price Change % | ||
|---|---|---|---|---|
| PNTG | 100% | +1.32% | ||
| ADUS - PNTG | 44% Loosely correlated | +3.16% | ||
| ENSG - PNTG | 43% Loosely correlated | +1.64% | ||
| UHS - PNTG | 42% Loosely correlated | -0.89% | ||
| AVAH - PNTG | 41% Loosely correlated | -0.08% | ||
| CON - PNTG | 40% Loosely correlated | +0.64% | ||
More | ||||